"Unveiling the Impact of AI in Healthcare: Stocks, Implementation, and Ethical Considerations"
TL;DR Summary
The potential of artificial intelligence (AI) in healthcare has attracted investor attention, with the market expected to reach $148 billion by 2029. Moderna, known for its COVID-19 vaccine, is utilizing AI in its pipeline and research processes, potentially leading to faster product development and new revenue sources. Medtronic, a medical device giant, has already secured approvals for AI-powered products and established an AI center of excellence, positioning itself for growth in the AI healthcare market. Both companies present long-term investment potential in the evolving landscape of AI in healthcare.
- 2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential The Motley Fool
- Here is how Capital Region hospitals are implementing AI Greater Baton Rouge Business Report
- Gaps emerge in how doctors and patients see AI Axios
- Generative AI is coming for healthcare, and not everyone’s thrilled TechCrunch
- Info-Tech Research Group Releases Blueprint for Ethical AI Implementation in the Healthcare Industry Morningstar
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
87%
710 → 89 words
Want the full story? Read the original article
Read on The Motley Fool